The exclusivity of the PlaniJens line is that it is the first Russian line of oral contraceptives, which includes the entire current list of combination oral contraceptives, thus increasing the availability of modern methods of pregnancy planning.

Safe contraception preserves the health of Russian women and results in a decrease in abortions and associated risks for reproductive function.

The DlyaJens line increases the affordability of endometriosis treatment and menopausal correction drugs for women in menopause, helping them make a painless transition from the reproductive period to the “autumn season” of life, smoothing out unpleasant symptoms and preventing serious consequences.

The presented hormonal drugs are produced and planned to be produced at the newly built Pharmasyntez-Tyumen plant, which is one of the largest in Europe and the only plant in Russia that fully specializes in the production of hormonal drugs.  

The plant already produces about 27 trade names of hormonal drugs and over 10 products are in the process of registration and development.

The drug products produced by Pharmasyntez are not inferior to their Western analogues in terms of quality and convenience of consumer packaging. For example, oral contraceptives are produced in a modern “smart case” package format, in which a special navigation system is developed and implemented for correct and timely administration of the drug, not only making the drug use as comfortable as possible, but also preventing the risk of missing the necessary pill.

Pharmasyntez considers concern about the health of Russian women as its priority.

Photo: Press Service of the Biotechmed Forum.